Serum Tartrate-Resistant Acid Phosphatase 5b or Amino-Terminal Propeptide of Type I Procollagen for Monitoring Bisphosphonate Therapy in Postmenopausal Osteoporosis?-Reference-Cited by-同舟云学术

Serum Tartrate-Resistant Acid Phosphatase 5b or Amino-Terminal Propeptide of Type I Procollagen for Monitoring Bisphosphonate Therapy in Postmenopausal Osteoporosis?

Published:2005-12-01 Issue:12 Volume:51 Page:2382-2385
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Välimäki Matti J¹,Tähtelä Riitta²

Affiliation:

1. Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

2. Mehiläinen Oy Laboratoriopalvelut, Helsinki, Finland

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/51/12/2382/32684455/clinchem2382.pdf

Reference16 articles.

1. Rosen CJ, Chesnut CH, III, Mallinak NJS. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab1997;82:1904-1910.

2. Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsay L, Karpf DB. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res1998;13:1431-1438.

3. Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, et al. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J Clin Endocrinol Metab1999;84:2363-2368.

4. Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab2004;89:1117-1123.

5. Blumsohn A, Eastell R. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice?. Ann Clin Biochem1997;34:449-459.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Bone Remodeling;Clinical and Laboratory Medicine Textbook;2023

2. Tartrate-Resistant Acid Phosphatase as a Biomarker of Bone Remodeling;Biomarkers in Bone Disease;2017

3. Osteogenic and anti-osteoporotic effects of risedronate-added calcium phosphate silicate cement;Biomedical Materials;2016-07-07

4. Tartrate-Resistant Acid Phosphatase as a Biomarker of Bone Remodeling;Biomarkers in Bone Disease;2016

5. Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications;Clinical Laboratory;2015